France Just Approved What the U.S. Still Won’t Name: IV Ketamine for Acute Suicidal Crisis
France's March 2026 approval of intravenous racemic ketamine for severe suicidal crisis is the first regulatory action of its...
Oral Brexanolone’s Phase 3 Failure Exposes a Gap Ketamine Already Fills
Lipocine's LPCN 1154 just failed its Phase 3 trial for postpartum depression, sending shares down 77%. For psychiatrists treating...
The GLP-1 Mood Signal Is Real — But So Is the Psychiatric Worsening Risk
A pattern I’ve been tracking across my dual-diagnosis patient panel this year: the patients who come in asking about...
The 42% Cost Drop That Should Rewrite How We Design OUD Trials
A pattern I’ve been tracking across my patient panel for the past several months: the patients most likely to...